Investigations Blog

On July 26, 2021, a bipartisan group of senators, led by Sen. Charles E. Grassley (R-Iowa), introduced the False Claims Amendments Act of 2021, a bill that would amend the False Claims Act (FCA) in several ways.

JD Supra has awarded our Investigations team with its 2021 Readers’ Choice Award as the Top Firm for White Collar analysis. The award comes during a year when the legal intelligence platform quadrupled its content production.

According to court documents, the defendant admitted to, among other things, distributing unnecessary compound prescriptions by adjusting prescriptions and paying recruiters commissions for procuring prescriptions for high-margin medications.

US-based multinational medical device company, Avanos Medical Inc., entered into a deferred prosecution agreement and agreed to pay more than $22 million in connection with a criminal complaint charging the company with one count of introducing misbranded surgical gowns in interstate commerce with t

A regional hospital system in Akron, Ohio, Akron General Health System (AGHS) reached a $21.25 million settlement over allegations that an improper physician referral arrangement violated the Anti-Kickback Statute, Physician Self-Referral Law, and the False Claims Act (FCA).

After an eight-day trial, a federal jury convicted four California residents for their scheme to submit fraudulent loan applications seeking millions of dollars in the Paycheck Protection Program (PPP) and Economic Injury Disaster Loan (EIDL) COVID-19 relief funds.

On June 23, 2021, CVS Pharmacy Inc. was cleared of claims of overcharging drug purchasers by more than $121 million for general drugs. This verdict comes after a week-long trial in the Northern District of California beginning June 7, 2021.

On June 15, 2021, the Department of Justice (DOJ) filed a False Claims Act (FCA) suit against Paksn Inc., Prema Thekkek and one of its owners, and seven skilled nursing facilities (SNFs) owned by Thekkek and/or operated by Paksn.

The owner of Campbell Medical Clinic in Houston and her medical group agreed to resolve fraudulent billing allegations for $2.6 million.

In addition to the ever-growing number of fraud charges brought in connection with the SBA’s PPP program, recent indictments issued across the country in connection with Covid-19 unemployment benefits and economic injury disaster loans further evince the DOJ’s continued priority to pursue Covid-19 r

On May 21, 2021, SavaSeniorCare LLC and several of its affiliates, which own and operate skilled nursing facilities across the country, agreed to pay $11.2 million to resolve claims that the companies billed Medicare for rehabilitation therapy services that were not reasonable or necessary.

Headlines that Matter for Companies and Executives in Regulated Industries

The National Law Journal spoke with Arent Fox Complex Litigation Practice Leader Jacques Smith last week about key trends in FCA enforcement for the Health Care industry.

Headlines that Matter for Companies and Executives in Regulated Industries

Headlines that Matter for Companies and Executives in Regulated Industries

Headlines that Matter for Companies and Executives in Regulated Industries

The Department of Justice is on high alert for situations when hype turns to fraud at tech startups.

Headlines that Matter for Companies and Executives in Regulated Industries.

Headlines that Matter for Companies and Executives in Regulated Industries

Arent Fox’s Investigations Blog provides legal updates and analysis on key enforcement news for companies and executives in highly regulated industries. 

Headlines that Matter for Companies and Executives in Regulated Industries

Headlines that Matter for Companies and Executives in Regulated Industries

Headlines that Matter for Companies and Executives in Regulated Industries

With SEC claims on the rise and the recent Whistleblower amendments, FinTech businesses will be well-served by reviewing their compliance operations and consulting with counsel as needed to mitigate avoidable risk. 

Headlines that Matter for Companies and Executives in Regulated Industries